Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)
Trial details
- Registry ID
- NCT04634669
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as AXS-05; dextromethorphan-bupropion
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)NCT04634669 | AXSM | Phase 2 | Terminated | 2022-02-18Actual |
| A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease AgitationNCT04947553 | AXSM | Phase 3 | Completed | 2024-12-03Actual |
| An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension StudyNCT06736509 | AXSM | Phase 3 | Terminated | 2025-02-17Actual |
| Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)NCT07766655 | AXSM | Phase 3 | Recruiting | 2027-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |